Will PARTNER 2 change my practice?

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Will PARTNER 2 change my practice? / Sawaya, Fadi J.; Søndergaard, Lars.

I: Interventional Cardiology Review, Bind 12, Nr. 2, 01.01.2017, s. 126-127.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Sawaya, FJ & Søndergaard, L 2017, 'Will PARTNER 2 change my practice?', Interventional Cardiology Review, bind 12, nr. 2, s. 126-127. https://doi.org/10.15420/icr.2016:29:2

APA

Sawaya, F. J., & Søndergaard, L. (2017). Will PARTNER 2 change my practice? Interventional Cardiology Review, 12(2), 126-127. https://doi.org/10.15420/icr.2016:29:2

Vancouver

Sawaya FJ, Søndergaard L. Will PARTNER 2 change my practice? Interventional Cardiology Review. 2017 jan. 1;12(2):126-127. https://doi.org/10.15420/icr.2016:29:2

Author

Sawaya, Fadi J. ; Søndergaard, Lars. / Will PARTNER 2 change my practice?. I: Interventional Cardiology Review. 2017 ; Bind 12, Nr. 2. s. 126-127.

Bibtex

@article{2348ddcbd7db4221b6d9a4779a20ab87,
title = "Will PARTNER 2 change my practice?",
abstract = "Transcatheter aortic valve implantation (TAVI) has become an established and increasingly-used technique to treat patients with severe aortic valve stenosis (AS) over the past decade. The clinical outcomes obtained with TAVI have been found to be equivalent to surgical aortic valve replacement (SAVR) in patients with a high-risk profile. Following the Placement of Aortic Transcatheter Valves (PARTNER) 1 trial, which demonstrated the utility of TAVI in inoperable and high-risk groups, the PARTNER 2 trial was implemented. PARTNER 2 reflects the current TAVI practice in Europe, confirms that transfemoral access is related to superior outcomes compared to SAVR in a selected population and demonstrates improved results with new-generation devices.",
keywords = "Aortic valve stenosis, Low risk, STS, Surgical aortic valve replacement, Transcatheter aortic valve implantation, Transfemoral access",
author = "Sawaya, {Fadi J.} and Lars S{\o}ndergaard",
year = "2017",
month = jan,
day = "1",
doi = "10.15420/icr.2016:29:2",
language = "English",
volume = "12",
pages = "126--127",
journal = "Interventional Cardiology: Reviews, Research, Resources",
issn = "1756-1477",
publisher = "Touch Briefings",
number = "2",

}

RIS

TY - JOUR

T1 - Will PARTNER 2 change my practice?

AU - Sawaya, Fadi J.

AU - Søndergaard, Lars

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Transcatheter aortic valve implantation (TAVI) has become an established and increasingly-used technique to treat patients with severe aortic valve stenosis (AS) over the past decade. The clinical outcomes obtained with TAVI have been found to be equivalent to surgical aortic valve replacement (SAVR) in patients with a high-risk profile. Following the Placement of Aortic Transcatheter Valves (PARTNER) 1 trial, which demonstrated the utility of TAVI in inoperable and high-risk groups, the PARTNER 2 trial was implemented. PARTNER 2 reflects the current TAVI practice in Europe, confirms that transfemoral access is related to superior outcomes compared to SAVR in a selected population and demonstrates improved results with new-generation devices.

AB - Transcatheter aortic valve implantation (TAVI) has become an established and increasingly-used technique to treat patients with severe aortic valve stenosis (AS) over the past decade. The clinical outcomes obtained with TAVI have been found to be equivalent to surgical aortic valve replacement (SAVR) in patients with a high-risk profile. Following the Placement of Aortic Transcatheter Valves (PARTNER) 1 trial, which demonstrated the utility of TAVI in inoperable and high-risk groups, the PARTNER 2 trial was implemented. PARTNER 2 reflects the current TAVI practice in Europe, confirms that transfemoral access is related to superior outcomes compared to SAVR in a selected population and demonstrates improved results with new-generation devices.

KW - Aortic valve stenosis

KW - Low risk

KW - STS

KW - Surgical aortic valve replacement

KW - Transcatheter aortic valve implantation

KW - Transfemoral access

U2 - 10.15420/icr.2016:29:2

DO - 10.15420/icr.2016:29:2

M3 - Review

AN - SCOPUS:85031000737

VL - 12

SP - 126

EP - 127

JO - Interventional Cardiology: Reviews, Research, Resources

JF - Interventional Cardiology: Reviews, Research, Resources

SN - 1756-1477

IS - 2

ER -

ID: 187312970